VanEck ChiNext Innovators ETF
CNXT
7 hedge funds and large institutions have $5.86M invested in VanEck ChiNext Innovators ETF in 2017 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 3 increasing their positions, 2 reducing their positions, and closing their positions.
50% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 2
0% more funds holding
Funds holding: 7 → 7 (0)
1.21% less ownership
Funds ownership: 27.27% → 26.05% (-1.2%)
11% less capital invested
Capital invested by funds: $6.55M → $5.86M (-$693K)
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $917K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
+$190K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$35.9K |
| 3 |
Simplex Trading
Chicago,
Illinois
|
+$13.2K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jane Street
New York
|
-$895K |
| 2 |
Bank of America
Charlotte,
North Carolina
|
-$101K |
CNXT Hedge Fund Activity: Q4 2017 in Review
7 of the 4,410 institutional investors tracked by Wall St. Rank reported a position in VanEck ChiNext Innovators ETF (CNXT) for Q4 2017, worth a combined $5.86M — down 11% from $6.55M a quarter earlier.
Fund positioning in CNXT was balanced in Q4 2017: 0 funds opened new positions, 0 closed out, 3 added to existing stakes and 2 trimmed.
The largest buyer was Morgan Stanley, adding an estimated $190K. The largest seller was Jane Street, cutting an estimated $895K.
- 7 institutional investors held VanEck ChiNext Innovators ETF (CNXT) as of Q4 2017, unchanged from Q3 2017.
- Funds reported $5.86M of VanEck ChiNext Innovators ETF stock for Q4 2017, down 11% quarter-over-quarter.
- 0 funds opened new VanEck ChiNext Innovators ETF positions in Q4 2017 and 0 closed out.
- The largest VanEck ChiNext Innovators ETF buyer in Q4 2017 was Morgan Stanley, an estimated $190K added.
- The largest VanEck ChiNext Innovators ETF seller in Q4 2017 was Jane Street, an estimated $895K sold.
Based on aggregated 13F filings for Q4 2017.